News features

June 5, 2018

EB Treatment Candidate BPM 31510 Granted Orphan Drug Designation in US

March 19, 2018

How Big Pharma is Using AI to Make Better Drugs

January 25, 2018

AI is Helping Turn Tide Against Flu in Two Important Ways

January 19, 2018

Flu Epidemic Could Cost Employers $9 Billion

January 16, 2018

Flu-pocalypse? Why Scientists are Scrambling to Make ‘Universal Influenza Vaccine’

December 15, 2017

BERG Teams with Mass General Hospital, Brigham and Women’s Hospital to Combat Alzheimer’s Disease

November 20, 2017

BERG, AstraZeneca Partnership Highlighted in Forbes Column

November 8, 2017

BERG Helps Establish McLeod Research Fellowship at USUHS

November 1, 2017

CEO Niven Narain Discusses Partnership with Sanofi Pasteur

October 31, 2017

BERG, Sanofi team up on AI-flu vaccine project

October 31, 2017

Sanofi turns to artificial intelligence to beat flu

October 19, 2017

BERG Supports PurpleStride 2017 in Fight Against Pancreatic Cancer

October 4, 2017

CSO Ranga Sarangarajan, CAO Slava Akmaev explain how embrace of AI has led to promising drug candidates

October 4, 2017

CEO Niven Narain Sheds Light on New Prostate Cancer Diagnostic Test Developed for DoD

September 5, 2017

CEO Niven Narain Discusses AI, AstraZeneca Partnership on BBC’s “Talking Business”

August 29, 2017

AstraZeneca Teams Up with BERG to Tackle Neurological Disease

August 28, 2017

AstraZeneca taps AI for drug discovery in deal with BERG

July 7, 2017

The Next Frontier for A.I.? Drug Research

June 26, 2017

Wall Street Journal: How AI Is Transforming Drug Creation

June 2, 2017

Pharma–Advocacy Partnerships: How the BERG–debra Partnership Helps EB Patients

March 10, 2017

Frontline Genomics talks to Ranga Sarangarajan about our AI guided GBM trials

BERG in the News!

BERG is making headlines.  Click here to see the latest breaking news, interviews, and press releases.